Provided by Tiger Trade Technology Pte. Ltd.

Alpha Tau Medical

14.92
+0.56003.90%
Pre-market: 15.140.2200+1.47%07:44 EDT
Volume:626.16K
Turnover:9.28M
Market Cap:1.38B
PE:-14.19
High:15.02
Open:14.57
Low:14.40
Close:14.36
52wk High:15.02
52wk Low:3.09
Shares:92.33M
Float Shares:63.79M
Volume Ratio:1.47
T/O Rate:0.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0517
EPS(LYR):-0.5300
ROE:-141.68%
ROA:-25.71%
PB:31.27
PE(LYR):-28.15

Loading ...

Alpha Tau Announces FDA Approval of Ide Supplement to Expand Alpha Dart® Impact Trial to Patients With Pancreatic Cancer Receiving Gemcitabine With Abraxane® (Nab-Paclitaxel)

THOMSON REUTERS
·
Apr 23

Alpha Tau Medical Ltd - Impact Trial Expanded to Recruit Total of 40 Patients

THOMSON REUTERS
·
Apr 23

Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Europe With Alpha Dart® in French Multicenter Acapella Clinical Trial

THOMSON REUTERS
·
Apr 23

BRIEF-Alpha Tau Announces First-Ever Oral Presentation Of Alpha Dart® Pancreatic Cancer Data At Digestive Disease Week (Ddw) 2026

Reuters
·
Mar 31

Alpha Tau Medical Ltd. files initial beneficial ownership statement for Director Nadav Kidron

Reuters
·
Mar 19

Alpha Tau Medical Director Samuel Morry Blumenfeld Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19

Alpha Tau Medical Ltd. Director David Mark Milch Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19

Alpha Tau Medical Ltd. Director Maya Netser Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19

Alpha Tau Medical Ltd. files Form 3 initial beneficial ownership statement for CFO Raphi Levy

Reuters
·
Mar 19

Alpha Tau CFO Raphi Levy to present at Sidoti Virtual Small Cap Conference

Reuters
·
Mar 16

Alpha Tau price target raised to $9 from $7 at Citi

TIPRANKS
·
Mar 11

Alpha Tau Medical Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 11

Alpha Tau Medical: U.S. Trial Expansion, Japan Approval, and Manufacturing Scale-Up Support Buy Rating Despite Near-Term Losses

TIPRANKS
·
Mar 11

Alpha Tau Medical Q4 EPS $(0.14) Misses $(0.12) Estimate

Benzinga Earnings
·
Mar 10

Alpha Tau FY2025 net loss rises 34% to USD 42.63 million

Reuters
·
Mar 10

Press Release: Alpha Tau Announces Full Year 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Mar 10

Alpha Tau Medical Shares Fall After Piper Sandler Downgrade

MT Newswires Live
·
Mar 05

Alpha Tau Medical Cut to Neutral From Overweight by Piper Sandler

Dow Jones
·
Mar 04

Alpha Tau downgraded to Neutral from Overweight at Piper Sandler

TIPRANKS
·
Mar 04

Alpha Tau Medical Ltd : Piper Sandler Cuts to Neutral From Overweight

THOMSON REUTERS
·
Mar 04